Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01855646 · ClinicalTrials.gov registry record · NA
Improved Patient Handoffs to Prevent Sentinel Events
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 4,344
- Enrollment target
NCT01855646: Completed NA study, sponsored by Duke University.
NCT01855646 is a NA study that has completed, run by Duke University. The registered enrollment target is 4,344 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (209% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01855646, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,344 participants
- Enrollment target
Study Summary
The overall aim of this project is to improve the quality of the handoffs between hospitalists on the general medicine service at Durham Regional Hospital with the intent of improving transitions of care. The intervention will be an improved and more structured face to face sign-out process using a standardized admission sign-out sheet, which is not part of the official medical record. Daytime admitting physicians will assign an acuity score to their patients in which the severity of illness will be scored from 1-7, with 7 being the most sick / likely to have rapid response team (RRT) or adverse event. The assignment of this score would be based off of the clinician's judgment in the patient's overall assessment. All patients, age \>18 years, admitted to the non-resident hospital medicine general medicine service at DRH will be study eligible. Data analysis will examine aggregate hospitalist perception of sign-out practice before and after intervention, total number of RRTs, unplanned transfers, and rapid responses pre and post intervention, percentage of hospitalist based patients of overall rapid responses pre and post intervention, percentage of hospitalists using acuity scores, and average and mean severity score of patients with rapid responses compared with those admitted. Patients have a risk of loss of confidentiality.
Interventions
- OTHER Structured Sign Out Form
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,344 participants |
| Est. Completion | 2014-01 |
| Phase | NA |
What the finished NCT01855646 record still lists
NCT01855646 is an interventional study that assigns participants to a tested intervention. Its 4,344 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (209% higher).
The record links to 0 conditions, and to 1 intervention - of which Structured Sign Out Form is the first listed.
NCT01855646 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01855646 about?
NCT01855646 is a clinical study titled "Improved Patient Handoffs to Prevent Sentinel Events". The overall aim of this project is to improve the quality of the handoffs between hospitalists on the general medicine service at Durham Regional Hospital with the intent of improving transitions of care. The intervention will be an improved and more structured face to face sign-out process using a ...
What is the current status of trial NCT01855646?
This trial is currently completed. It is a NA study. The enrollment target is 4,344 participants. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01855646?
The interventions under investigation include: Structured Sign Out Form (OTHER).
Who is sponsoring clinical trial NCT01855646?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01855646's enrollment target sits among peer trials
4,344 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children